<DOC>
	<DOCNO>NCT02288117</DOCNO>
	<brief_summary>The objective PMCF collect clinical radiographic outcome information Total Hip Arthroplasty ( THA ) perform LINK® SP-CL® Hip Prosthesis Stem routine condition . The result collect used clinically confirm performance safety LINK® SP-CL® Hip Prosthesis Stem term manufacturer 's obligation perform PMCF . Furthermore result use future regulatory process need .</brief_summary>
	<brief_title>Prospective Clinical 5-year Follow-up LINK® SP-CL® Hip Prosthesis Stem</brief_title>
	<detailed_description>Post Market Clinical Follow-ups ( PMCF ) observational study important tool detect infrequent complication problem , event specific define patient population long term performance issue routine condition [ 2,3 ] . Against background prospective multi-center outcome study LINK® SP-CL® plan .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Osteoarthritis , Hip</mesh_term>
	<mesh_term>Femoral Neck Fractures</mesh_term>
	<mesh_term>Femur Head Necrosis</mesh_term>
	<criteria>Skeletally mature Subject agree comply require postoperative management followup evaluation Undergone least six ( 6 ) month unsuccessful , conservative , nonsurgical treatment Patient understand condition study willing able comply postoperative schedule clinical radiographic evaluation prescribe postoperative management . Patient sign Informed Consent . Body Mass Index ( BMI ) &gt; 40 kg/m2 Poor general state health Acute chronic infection , local systemic Pharmaceutical drug abuse , alcoholism Allergies implant material Distinctive muscular , nerve , vascular disease put affected limb risk Insufficient / inadequate bone mass quality prevents stable anchorage prosthesis Severe osteoporosis Foreseeable overload/ overstress joint prosthesis Acetabular defect Female patient pregnant plan become pregnant course study Prisoner Patient , judge surgeon , mentally incompetent unlikely compliant prescribe postoperative routine followup evaluation schedule Patient sign Informed Consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>PMCF</keyword>
	<keyword>Post Market Clinical Follow</keyword>
	<keyword>SP-CL</keyword>
	<keyword>anatomic stem</keyword>
</DOC>